We are delighted by today's decision to allow patients with advanced prostate cancer to receive abiraterone on the NHS.
This drug was discovered at the Institute of Cancer Research and is the result of more than two decades of dedicated work by our scientists and and collaborators.
In clinical trials of men with advanced prostate cancer who have already tried chemotherapy, it has been shown to extend life by an average of four months and improve quality of life.
More top news
Thousands of pounds of NHS cash is being spent on holidays, aromatherapy and even summer houses for patients, according to research
Welfare reforms do not lead to more people being in work, a new study suggests.
A new vaccine to protect young children from meningitis is to be offered across the UK from today.